AMRN

Amarin (AMRN)

Amarin Corp PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AMRN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/23	06:49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMRN	Amarin Corp PLC
2024/11/11	22:00	GlobeNewswire Inc.	Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual	NASDAQ:AMRN	Amarin Corp PLC
2024/11/01	05:42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AMRN	Amarin Corp PLC
2024/10/31	05:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AMRN	Amarin Corp PLC
2024/10/31	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMRN	Amarin Corp PLC
2024/10/31	05:05	GlobeNewswire Inc.	Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:AMRN	Amarin Corp PLC
2024/10/01	21:00	GlobeNewswire Inc.	Amarin Announces Two Upcoming Investor Events	NASDAQ:AMRN	Amarin Corp PLC
2024/09/09	20:30	GlobeNewswire Inc.	Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe	NASDAQ:AMRN	Amarin Corp PLC
2024/08/22	21:30	GlobeNewswire Inc.	Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress	NASDAQ:AMRN	Amarin Corp PLC
2024/08/06	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMRN	Amarin Corp PLC
2024/08/02	05:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMRN	Amarin Corp PLC
2024/08/02	05:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMRN	Amarin Corp PLC
2024/07/31	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMRN	Amarin Corp PLC
2024/07/31	20:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AMRN	Amarin Corp PLC
2024/07/31	20:00	GlobeNewswire Inc.	Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:AMRN	Amarin Corp PLC
2024/07/30	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMRN	Amarin Corp PLC
2024/07/18	05:15	GlobeNewswire Inc.	Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal	NASDAQ:AMRN	Amarin Corp PLC
2024/07/17	21:00	GlobeNewswire Inc.	Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024	NASDAQ:AMRN	Amarin Corp PLC
2024/07/08	20:30	GlobeNewswire Inc.	Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)	NASDAQ:AMRN	Amarin Corp PLC
2024/06/04	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMRN	Amarin Corp PLC
2024/06/04	20:30	GlobeNewswire Inc.	Amarin Board of Directors Announces CEO Transition	NASDAQ:AMRN	Amarin Corp PLC
2024/05/28	21:15	GlobeNewswire Inc.	Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.	NASDAQ:AMRN	Amarin Corp PLC
2024/05/06	21:00	GlobeNewswire Inc.	Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference	NASDAQ:AMRN	Amarin Corp PLC
2024/05/01	20:00	GlobeNewswire Inc.	Amarin Reports First Quarter 2024 Business Update and Financial Results	NASDAQ:AMRN	Amarin Corp PLC
2024/04/25	03:00	GlobeNewswire Inc.	Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event	NASDAQ:AMRN	Amarin Corp PLC
2024/04/22	21:00	GlobeNewswire Inc.	Amarin Announces Results of Annual General Meeting of Shareholders	NASDAQ:AMRN	Amarin Corp PLC
2024/04/15	21:00	GlobeNewswire Inc.	Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024	NASDAQ:AMRN	Amarin Corp PLC
2024/04/08	21:00	GlobeNewswire Inc.	Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24	NASDAQ:AMRN	Amarin Corp PLC
2024/04/08	19:30	PR Newswire (Canada)	New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	NASDAQ:AMRN	Amarin Corp PLC
2024/04/07	04:30	GlobeNewswire Inc.	New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	NASDAQ:AMRN	Amarin Corp PLC